EDMOND DE ROTHSCHILD (SUISSE) S.A. - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD (SUISSE) S.A. ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$5,0000.0%1,5000.0%0.00%0.0%
Q2 2016$5,0000.0%1,5000.0%0.00%0.0%
Q1 2016$5,000
-90.6%
1,500
-87.0%
0.00%
-90.0%
Q4 2015$53,000
-20.9%
11,500
+4.5%
0.02%
-13.0%
Q3 2015$67,000
-48.1%
11,000
-26.7%
0.02%
-43.9%
Q2 2015$129,00015,0000.04%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Abingworth LLP 861,723$1,174,0000.98%
R&F Capital Advisors LP 171,205$111,0000.04%
Rhenman & Partners Asset Management AB 200,000$130,0000.02%
Rock Springs Capital Management LP 380,000$247,0000.02%
WHITE PINE CAPITAL LLC 35,000$23,0000.01%
BVF INC/IL 62,292$40,0000.01%
Virtu KCG Holdings LLC 271,239$176,0000.00%
TURNER INVESTMENTS LLC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 11,736$8,0000.00%
Tower Research Capital LLC (TRC) 36,413$24,0000.00%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders